Biotech · Public company · Seattle, WA, US

Achieve Life Sciences, Inc.

Ticker ACHV · SEC CIK 0000949858

Track this companyFree. Adds Achieve Life Sciences, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials80 recruiting or active

Pipeline programs7From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline7

Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette SmokersPHASE3 · COMPLETED · started May 28, 2024ClinicalTrials.gov NCT06435221 · fetched Nov 12, 2026
A Study of Cytisinicline for Vaping Cessation in Adult SmokersPHASE2 · COMPLETED · started Jul 13, 2022ClinicalTrials.gov NCT05431387 · fetched Nov 12, 2026
A Second Study of Cytisinicline for Smoking Cessation in Adult SmokersPHASE3 · COMPLETED · started Jan 20, 2022ClinicalTrials.gov NCT05206370 · fetched Nov 12, 2026
A Study of Cytisinicline for Smoking Cessation in Adult SmokersPHASE3 · COMPLETED · started Oct 13, 2020ClinicalTrials.gov NCT04576949 · fetched Nov 12, 2026
Trial of Cytisine in Adult SmokersPHASE2 · COMPLETED · started Nov 13, 2018ClinicalTrials.gov NCT03709823 · fetched Nov 12, 2026
Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder CancerPHASE2 · COMPLETED · started Apr 1, 2013ClinicalTrials.gov NCT01780545 · fetched Nov 12, 2026
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving AbirateronePHASE2 · TERMINATED · started Dec 1, 2012ClinicalTrials.gov NCT01681433 · fetched Nov 12, 2026
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung CancerPHASE3 · COMPLETED · started Oct 24, 2012ClinicalTrials.gov NCT01630733 · fetched Nov 12, 2026